Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 11, 2025Heart ViewsOpen Access

Impact of Myocardial Fibrosis in Endurance Athletes: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

RKRasha KaddouraHAHassan Al-Tamimi

Discussion

Loading...

Member takes

Overview

Systematic review finds myocardial fibrosis prevalence of 13% to 48% in endurance athletes, highlighting potential clinical implications.

Key Points

  • Myocardial fibrosis prevalence among endurance athletes ranges from 13% to 48%, posing cardiovascular risks.
  • Impact on ventricular function and volume shows inconsistent results across studies evaluated.
  • Systematic review analyzed data from eight trials involving 470 athletes for comprehensive insights.
  • Prognostic implications of myocardial fibrosis for clinical outcomes like arrhythmias were not thoroughly reported.

Cite This Study

Kaddoura et al. (2025) studied this question.

synapsesocial.com/papers/68c2354db210217d6476fb2ahttps://doi.org/10.4103/heartviews.heartviews_13_23
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myocardial fibrosis and its relationship with ventricular arrhythmias and reduced ventricular systolic function in young and veteran endurance athletes2025
  2. 2Adaptive Changes in Endurance Athletes: A Review of Molecular, Echocardiographic and Electrocardiographic Findings2025
  3. 3Cardiovascular Remodeling and Potential Controversies in Master Endurance Athletes—A Narrative Review2025
  4. 4Therapeutic Targets for Myocardial Fibrosis: A Comprehensive Review of Current and Emerging Approaches2025
  5. 5Left Ventricular Fibrosis in Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: A Comprehensive Review of Mechanisms, Clinical Implications, and Therapeutic Perspectives2026